Self-Reinforcing CGRP Feedback Loop Discovered as Driver of Chronic Migraine

Researchers discovered a self-reinforcing feedback loop — CREB→KIF1A→CGRP→CREB — that drives chronic migraine. CREB directly activates transcription of KIF1A (a motor protein), which physically associates with CGRP and promotes its transport and expression. CGRP signaling then feeds back to reactivate CREB, creating a positive loop. Disrupting any component of this axis — inhibiting CREB, knocking down KIF1A, or blocking the CGRP receptor — effectively reduced migraine-like pain behaviors and molecular markers of central sensitization in mice.

Chronic migraine was modeled in mice using repeated nitroglycerin injections. Researchers used behavioral testing (thermal/mechanical allodynia), molecular analyses (immunoblotting, qPCR, immunofluorescence), ChIP and dual-luciferase assays (to confirm CREB binds Kif1a promoter), co-immunoprecipitation (KIF1A-CGRP interaction), synaptosomal analysis (vesicle CGRP levels), and pharmacological interventions (Forskolin/CREB agonist, 666-15/CREB inhibitor, Kif1a knockdown/overexpression, Olcegepant/CGRP receptor antagonist).

While CGRP is a proven migraine target, why it stays elevated in chronic migraine has been unclear. This study explains the mechanism: a feedback loop keeps CGRP production running. Understanding this loop reveals new upstream targets (CREB, KIF1A) that could be blocked to treat chronic migraine, potentially offering alternatives for patients who don't respond to anti-CGRP antibodies. It also explains how episodic migraine may become chronic through self-sustaining CGRP signaling.

This study provides a mechanistic explanation for migraine chronification — how occasional migraines become frequent, disabling chronic migraines. The discovery of an upstream regulatory loop controlling CGRP could explain why some patients don't respond to anti-CGRP antibodies (the loop may maintain sensitization through other pathways) and suggests that combination approaches targeting multiple loop components could be more effective than CGRP blockade alone.

This is a mouse model study using nitroglycerin-induced migraine, which may not fully recapitulate human chronic migraine. The interventions (gene knockdown, CREB inhibitors) are not yet available as clinical treatments. The feedback loop was characterized primarily in spinal trigeminal neurons and Neuro-2a cells, and additional brain regions involved in migraine were not examined.